BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5573439)

  • 21. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggregation of duck thrombocytes by 5-hydroxytryptamine.
    Belamarich FA; Simoneit LW
    Microvasc Res; 1973 Sep; 6(2):229-34. PubMed ID: 4748022
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
    Weiss HJ; Tschopp TB; Rogers J; Brand H
    J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of intravascular aggregation by continuous platelet counting.
    Smith GM; Freuler F
    Bibl Anat; 1973; 12():229-34. PubMed ID: 4790356
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet serotonin in patients with analgesic-induced headache.
    Srikiatkhachorn A; Anthony M
    Cephalalgia; 1996 Oct; 16(6):423-6. PubMed ID: 8902251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin infusions inhibit sensory input from the dural vasculature.
    Lambert GA; Shimomura T; Boers PM; Gordon V; Donaldson C; Zagami AS
    Cephalalgia; 1999 Sep; 19(7):639-50. PubMed ID: 10524657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A; Laubscher A; Graf M; Saner A
    Ann Biol Clin (Paris); 1979; 37(1):35-9. PubMed ID: 443611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet serotonin measures in migraine.
    Jernej B; Vladić A; Cicin-Sain L; Hranilović D; Banović M; Balija M; Bilić E; Sucić Z; Vukadin S; Grgicević D
    Headache; 2002; 42(7):588-95. PubMed ID: 12482210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of mechanisms of amine storage in the dense bodies of human platelets.
    Costa JL; Eanes ED
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):347-66. PubMed ID: 6095385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet 5-hydroxytryptamine and adenine nucleotides, serum arginylesterase and plasma 11-hydroxycorticosteroids in migraine.
    Hinterberger H; Anthony M; Vagholkar MK
    Clin Sci; 1968 Apr; 34(2):271-6. PubMed ID: 5653687
    [No Abstract]   [Full Text] [Related]  

  • 32. The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology.
    Pletscher A
    Int J Cardiol; 1987 Feb; 14(2):177-88. PubMed ID: 3818134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of platelet Met-enkephalin, but not serotonin, in migraine. A platelet response unique to migraine patients?
    Ferrari MD; Odink J; Frölich M; Tapparelli C; Portielje JE
    J Neurol Sci; 1989 Oct; 93(1):51-60. PubMed ID: 2809630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.
    Baumgartner HR; Born GV
    J Physiol; 1969 Apr; 201(2):397-408. PubMed ID: 5780549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
    Pietraszek MH; Takada Y; Takada A; Fujita M; Watanabe I; Taminato A; Yoshimi T
    Thromb Res; 1992 Jun; 66(6):765-74. PubMed ID: 1519234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine: a platelet disorder.
    Hanington E; Jones RJ; Amess JA; Wachowicz B
    Lancet; 1981 Oct; 2(8249):720-3. PubMed ID: 6116859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The action of reserpine on the concentration of 5-hydroxytryptamine, epinephrine and norepinephrine in the venous blood of migraine patients].
    Genefke IK; Bryndum B; Dalsgaard-Nielsen T; Fog-Moller F
    Minerva Med; 1976 Jun; 67(28):1876-82. PubMed ID: 934535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.
    Fetkovska N; Pletscher A; Ferracin F; Amstein R; Buhler FR
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():105-9. PubMed ID: 1704794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in density and accumulation of serotonin by human aging platelets.
    Mezzano D; Aranda E; Rodríguez S; Foradori A; Lira P
    Am J Hematol; 1984 Jul; 17(1):11-21. PubMed ID: 6741929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R; Fetkovska N; Pletscher A; Bühler FR
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.